72.30
-0.32 (-0.44%)
-0.32 (-0.44%)
Upgrade to Real-Time
Afterhours
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | MRK | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.32 | -0.44% | 72.30 | 18:32:29 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 73.21 | 72.18 | 73.39 | 72.38 | 72.62 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 84,919 | 12,021,226 | $ 73.01 | $ 877,712,422 | 9,651,539 | 65.25 - 87.80 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:36:01 | 60 | $ 72.40 | USD |
Merck Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 182.92B | 2.53B | 2.53B | $ 46.84B | $ 12.11B | 3.81 | 17.90 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 2.26 | 3.13% | - | - |
Merck News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 74.49 | 75.959 | 72.18 | 74.15 | 10,572,186 | -2.19 | -2.94% |
| 1 Month | 77.89 | 78.92 | 72.18 | 75.16 | 11,006,831 | -5.59 | -7.18% |
| 3 Months | 82.02 | 85.60 | 72.18 | 78.76 | 10,137,338 | -9.72 | -11.85% |
| 6 Months | 85.43 | 87.80 | 72.18 | 80.01 | 9,238,155 | -13.13 | -15.37% |
| 1 Year | 77.36 | 87.80 | 65.25 | 78.96 | 10,118,493 | -5.06 | -6.54% |
| 3 Years | 54.26 | 92.64 | 52.83 | 76.48 | 9,983,898 | 18.04 | 33.25% |
| 5 Years | 50.39 | 92.64 | 50.0901 | 70.36 | 9,613,031 | 21.91 | 43.48% |
Merck Description
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the firm's sales are generated in the United States. |
